Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.
about
Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathyUnraveling oxyntomodulin, GLP1's enigmatic brotherCardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure.Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited.New Modalities for Challenging Targets in Drug Discovery.The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis.Glucagon signaling in the heart: Activation or inhibition?Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction.On-target effects of GLP-1 receptor agonists on thyroid C-cells in rats and mice.Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives.Drugs with dual-hormone action gain attention in diabetes field.Procedure for calculation of potency and efficacy for ligands acting on Gs- and Gi-coupled receptors.ZP2495 Protects against Myocardial Ischemia/Reperfusion Injury in Diabetic Mice through Improvement of Cardiac Metabolism and Mitochondrial Function: The Possible Involvement of AMPK-FoxO3a Signal Pathway.
P2860
Q26859582-D7362053-1D3E-4DFC-BBE7-9757D90BD05FQ27001704-F9FC6885-4EEA-43A3-BE21-F8521559AE1EQ34396881-0DC6F17A-98B1-4D2E-800C-7264A5773B49Q38218639-FDF1316E-D250-41DF-BE15-96DE605694A6Q38289100-AE2EC11B-196D-402F-B803-143DA9C7DD09Q39283204-507ECA00-9FD7-4017-93A8-C8B74D946F6EQ41926540-03D0BB45-CBA9-499D-BDEF-1B60871EEAE2Q42170069-67FB57A2-29CE-4246-A194-AD2C58E88150Q42712582-6082964C-865B-4E84-A2E2-BF1CE468FB71Q43238779-CE356503-A81C-4DEC-A7F5-F3A1C53DE8C8Q44157852-404F22D9-8FBC-427D-B9A6-F34F67C167E1Q44699018-D0217DAD-A539-4C1E-B98B-36C64ED1BB59Q51731634-F2263691-9432-47E7-B722-6848154AAB23
P2860
Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Glucagon and a glucagon-GLP-1 ...... s in insulin-resistant hearts.
@ast
Glucagon and a glucagon-GLP-1 ...... s in insulin-resistant hearts.
@en
type
label
Glucagon and a glucagon-GLP-1 ...... s in insulin-resistant hearts.
@ast
Glucagon and a glucagon-GLP-1 ...... s in insulin-resistant hearts.
@en
prefLabel
Glucagon and a glucagon-GLP-1 ...... s in insulin-resistant hearts.
@ast
Glucagon and a glucagon-GLP-1 ...... s in insulin-resistant hearts.
@en
P2093
P2860
P50
P1476
Glucagon and a glucagon-GLP-1 ...... ts in insulin-resistant hearts
@en
P2093
A L Kjølbye
G D Lopaschuk
H D Pedersen
J S Petersen
L N Axelsen
P2860
P304
P356
10.1111/J.1476-5381.2011.01714.X
P407
P577
2012-04-01T00:00:00Z